Sirio Pharma Capital Reinvestment Ratio
Sirio Pharma capital reinvestment ratio. Sirio Pharma (300791) has a Capital Reinvestment Ratio of 0.59x as of June 2023, meaning it reinvests 1% of its operating cash flow (CN¥101.61 Million) in capital expenditures (CN¥59.65 Million). See Sirio Pharma free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sirio Pharma (2017–2024)
Capital reinvestment ratio of Sirio Pharma from 2017 to 2024. This chart tracks Sirio Pharma's Capital Reinvestment Ratio across 8 annual periods. See Sirio Pharma free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Sirio Pharma Capital Reinvestment Ratio by Year (2017–2024)
Sirio Pharma capital reinvestment ratio by year from 2017 to 2024. For the full cash flow conversion analysis, see 300791 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.73x | CN¥566.97 Million | CN¥412.13 Million | ▼ -37.9% |
| 2023 | 1.17x | CN¥386.08 Million | CN¥451.70 Million | ▲ +77.2% |
| 2022 | 0.66x | CN¥444.86 Million | CN¥293.69 Million | ▼ -57.0% |
| 2021 | 1.54x | CN¥341.38 Million | CN¥524.68 Million | ▲ +120.1% |
| 2020 | 0.70x | CN¥319.57 Million | CN¥223.14 Million | ▼ -3.1% |
| 2019 | 0.72x | CN¥231.60 Million | CN¥166.90 Million | ▼ -44.8% |
| 2018 | 1.30x | CN¥183.46 Million | CN¥239.32 Million | ▼ -59.7% |
| 2017 | 3.24x | CN¥49.35 Million | CN¥159.82 Million | — |